At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 16 enrolled
Drug / intervention
Gemfibrozil +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Gemfibrozil for Nicotine Smoking Cessation
University of Texas Southwestern Medical Center·interventional·Posted Dec 23, 2015·Updated Feb 1, 2019
In Brief
A Phase 2 clinical trial evaluating Gemfibrozil and smoking cessation counseling for Smoking Cessation. Completed, enrolled 16 participants across 1 site.
Detailed Summary
This project will test whether gemfibrozil, a well-studied medication for high cholesterol, will help people stop smoking nicotine cigarette smoking. The study will also test whether gemfibrozil decrease cravings for cigarette and the desire to smoke.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSmoking Cessation
CountriesUnited States
Collaborators--
Timeline
Phase 2CompletedFinished
201520162017201820192020202120222023202420252026
Enrollment StartFeb 2015
First PostedDec 2015
Primary CompletionDec 2016
TodayJul 2026
First PostedDec 23, 2015
Enrollment StartFeb 1, 2015
Primary CompletionDec 23, 2016
TodayJul 2, 2026
Enrollment to primary: 1.9 yearsPosted 10.5 years ago
Interventions
Gemfibrozildrug
FDA Approved Drug(s)/Biologic(s) (study use is not an FDA-approved use)
smoking cessation counselingbehavioral
smoking cessation counseling